lead position
Patents
Features list
-
There are several take-homes for brand owners in the wake of Sky v SkyKick, including a ray of light for owners of broad trademark specifications, according to Hogan Lovells’ international IP team
-
Biopharma companies can minimise the threat of compulsory licensing by taking strategic steps that benefit both business and patients, says April Abele Isaacson of Kilpatrick Townsend
-
IP counsel should consider recommending NFTs to clients who would like to monetise their patents, says Cameron Pick of Marshall, Gerstein & Borun
-
Yuji Orita and Toshihiro Nakane of NGB Corporation analyse the patent landscape for the latest Wi-Fi 6 standard, IEEE802.11ax
-
The globalisation of the biopharma industry has made it increasingly essential for companies to consider parallel patent proceedings across multiple countries, as April Abele Isaacson of Kilpatrick Townsend explains
-
AI has fundamentally and permanently disrupted the invention process, but the impact on patents is still unclear, says Ed White of Clarivate
Local Insights